Sunaina von Garlen Selected Research

Insulin Resistance

10/2018

Purinergic receptor Y2 (P2Y2)- dependent VCAM-1 expression promotes immune cell infiltration in metabolic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sunaina von Garlen Research Topics

Disease

3	Inflammation (Inflammations) 01/2022 - 06/2017
2	Atherosclerosis 01/2022 - 06/2017
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018
1	Obesity 10/2018
1	Insulin Resistance 10/2018

Drug/Important Bio-Agent (IBA)

3	CholesterolIBA 01/2022 - 06/2017
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 10/2018
2	LDL Receptors (LDL Receptor)IBA 01/2022 - 06/2017
2	Purinergic Receptors (Receptors, Purine)IBA 01/2022 - 10/2018
2	Purinergic P2 Receptors (ADP Receptor)IBA 01/2022 - 10/2018
2	InflammasomesIBA 01/2022 - 06/2017
1	NucleotidesIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	CC ChemokinesIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	CytokinesIBA 01/2022
1	LigandsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2018
1	C-PeptideIBA 10/2018
1	Insulin (Novolin)FDA Link 10/2018

Therapy/Procedure

1	Carotid Endarterectomy 01/2022